Search results

Page results

• UCLH creating a toolkit to make more clinical trials open to young people

  A new research project spearheaded by the CCTU at UCLH is trying to make more places on clinical trials available to young cancer patients aged between 16 and 24 years.

• Aftercare Guidance Following an Intrathecal Baclofen Pump Implant

  Information for patients (or anyone who is involved in their care) who have undergone implantation of an Intrathecal Baclofen Pump under the care of the team at this hospital.

• Molecular Radiotherapy Series No. 6 - Information for parents of children and young people having radioactive iodine (131I) treatment

  This page is for parents, carers and family members who are acting as comforters and carers for children and young people having radioactive iodine (131I) treatment. It explains what the treatment involves, how to prepare for it and what you can expect afterwards.

• New government support for energy bills. What does it mean? - by Jelena Nenadic, welfare and benefit advisor

  Information about the new government support available to help people pay their energy bills.

• Introduction to the Lymphoedema Service: Video and telephone consultation

  This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a video or telephone appointment.

• UCLH doses first patient in the world in Covid-19 antibody trial

  UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.

• Staff and patients delighted with the newly refurbished Neurorehabilitation Unit

  The Neurorehabilitation Unit (NRU) at The National Hospital for Neurology and Neurosurgery (NHNN) has been refurbished with funding from The National Brain Appeal to provide new facilities and additional space, transforming it into a more therapeutic environment.

• World-first CJD treatment shows promising early results

  A world-first treatment for Creutzfeldt-Jakob disease (CJD) has shown “very encouraging” early results following its use in six patients at University College London Hospitals (UCLH) NHS Foundation Trust.

• The importance of clinical trials in identifying tomorrow’s treatment options

  Today is International Clinical Trials Day, an important day on the UCLH calendar because research is an integral part of UCLH’s mission.

• UCLH to be part of vital health data partnership

  UCLH is to work in partnership with University Hospitals Birmingham NHS Foundation Trust in a major digital health initiative in which researchers use data collected in acute care settings to improve patient care.